Paper21394633
Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.
Newman-Tancredi A and 1 other. Psychopharmacology (Berl), 2011. Cited by 129 papers, by iCite.
Cite this record
ConductScience Library. Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties. Papers, record 21394633. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21394633
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipsychotic Agents | Major topic |
| Dopamine D2 Receptor Antagonists | Major topic |
| Serotonin 5-HT1 Receptor Agonists | Major topic |
| Animals | |
| Basal Ganglia Diseases | |
| Humans | |
| Models, Biological | |
| Protein Binding | |
| Receptors, Dopamine D2 | |
| Schizophrenia |
Source PubMed
References211
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16554049 | Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release. | Eur J Pharmacol | 2006 | https://conductscience.org/library/papers/16554049 | PubMed |
| 2 | 17391821 | Effective adjunctive use of tandospirone with perospirone for enhancing verbal memory and quality of life in schizophrenia. | Prog Neuropsychopharmacol Biol Psychiatry | 2007 | https://conductscience.org/library/papers/17391821 | PubMed |
| 3 | 19909227 | Third generation antipsychotic drugs: partial agonism or receptor functional selectivity? | Curr Pharm Des | 2010 | https://conductscience.org/library/papers/19909227 | PubMed |
| 4 | 2884687 | Provocative tests with psychostimulant drugs in schizophrenia. | Psychopharmacology (Berl) | 1987 | https://conductscience.org/library/papers/2884687 | PubMed |
| 5 | 14507979 | Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. | J Neurosci | 2003 | https://conductscience.org/library/papers/14507979 | PubMed |
| 6 | 15900318 | N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors. | Neuropsychopharmacology | 2005 | https://conductscience.org/library/papers/15900318 | PubMed |
| 7 | 16237386 | Estrogen prevents 5-HT1A receptor-induced disruptions of prepulse inhibition in healthy women. | Neuropsychopharmacology | 2006 | https://conductscience.org/library/papers/16237386 | PubMed |
| 8 | 18621404 | Serotonergic approaches in the development of novel antipsychotics. | Neuropharmacology | 2008 | https://conductscience.org/library/papers/18621404 | PubMed |
| 9 | 19464324 | Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys. | Behav Brain Res | 2009 | https://conductscience.org/library/papers/19464324 | PubMed |
| 10 | 18772034 | Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. | Prog Brain Res | 2008 | https://conductscience.org/library/papers/18772034 | PubMed |
| 11 | 20571978 | Cariprazine, an orally active D2/D3 receptor antagonist, for the potential treatment of schizophrenia, bipolar mania and depression. | Curr Opin Investig Drugs | 2010 | https://conductscience.org/library/papers/20571978 | PubMed |
| 12 | 16326078 | Plasma antipsychotic concentration and receptor occupancy, with special focus on risperidone long-acting injectable. | Eur Neuropsychopharmacol | 2006 | https://conductscience.org/library/papers/16326078 | PubMed |
| 13 | 12589516 | Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study. | Psychopharmacology (Berl) | 2003 | https://conductscience.org/library/papers/12589516 | PubMed |
| 14 | 17242925 | Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies. | Psychopharmacology (Berl) | 2007 | https://conductscience.org/library/papers/17242925 | PubMed |
| 15 | 14972078 | Do we still believe in the dopamine hypothesis? New data bring new evidence. | Int J Neuropsychopharmacol | 2004 | https://conductscience.org/library/papers/14972078 | PubMed |
| 16 | 12680740 | The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. | J Psychopharmacol | 2003 | https://conductscience.org/library/papers/12680740 | PubMed |
| 17 | 15649104 | Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death. | Drug Saf | 2005 | https://conductscience.org/library/papers/15649104 | PubMed |
| 18 | 12955285 | NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. | Psychopharmacology (Berl) | 2003 | https://conductscience.org/library/papers/12955285 | PubMed |
| 19 | 9152998 | [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. | Neurochem Int | 1997 | https://conductscience.org/library/papers/9152998 | PubMed |
| 20 | 20410873 | The antipsychotics olanzapine, risperidone, clozapine, and haloperidol are D2-selective ex vivo but not in vitro. | Neuropsychopharmacology | 2010 | https://conductscience.org/library/papers/20410873 | PubMed |
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42664351 | The structure of the dopamine D3 receptor bound to cariprazine reveals principles for partial agonists with designed pharmacology. | Sci Adv | 2026 | https://conductscience.org/library/papers/42664351 | PubMed |
| 41304890 | Review of Autism Spectrum Disorder (ASD): Epidemiology, Aetiology, Pathology, and Pharmacological Treatment. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41304890 | PubMed |
| 41097070 | Gepirone for Major Depressive Disorder: From Pharmacokinetics to Clinical Evidence: A Narrative Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41097070 | PubMed |
| 40064751 | Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models. | Pharmacol Rep | 2025 | https://conductscience.org/library/papers/40064751 | PubMed |
| 37732133 | Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis. | Schizophr Res Cogn | 2023 | https://conductscience.org/library/papers/37732133 | PubMed |
| 37549917 | In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate Antipsychotics. | Int J Neuropsychopharmacol | 2023 | https://conductscience.org/library/papers/37549917 | PubMed |
| 37470979 | Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia. | CNS Drugs | 2023 | https://conductscience.org/library/papers/37470979 | PubMed |
| 36813773 | Seasonality of brain function: role in psychiatric disorders. | Transl Psychiatry | 2023 | https://conductscience.org/library/papers/36813773 | PubMed |
| 36721972 | Effect of 5-HT1A Receptor Partial Agonists of the Azapirone Class as an Add-On Therapy on Psychopathology and Cognition in Schizophrenia: A Systematic Review and Meta-Analysis. | Int J Neuropsychopharmacol | 2023 | https://conductscience.org/library/papers/36721972 | PubMed |
| 36700327 | Cariprazine - an Alternative Treatment for Clozapine-resistant Schizophrenia? | Clin Psychopharmacol Neurosci | 2023 | https://conductscience.org/library/papers/36700327 | PubMed |
| 36661568 | Dopamine D3/D2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders. | J Med Chem | 2023 | https://conductscience.org/library/papers/36661568 | PubMed |
| 35434766 | 8-OH-DPAT enhances dopamine D2-induced maternal disruption in rats. | J Comp Physiol A Neuroethol Sens Neural Behav Physiol | 2022 | https://conductscience.org/library/papers/35434766 | PubMed |
| 35022720 | Dual 5-HT3 and 5-HT6 Receptor Antagonist FPPQ Normalizes Phencyclidine-Induced Disruption of Brain Oscillatory Activity in Rats. | Int J Neuropsychopharmacol | 2022 | https://conductscience.org/library/papers/35022720 | PubMed |
| 34376825 | Binding of SEP-363856 within TAAR1 and the 5HT1A receptor: implications for the design of novel antipsychotic drugs. | Mol Psychiatry | 2022 | https://conductscience.org/library/papers/34376825 | PubMed |
| 33805130 | Development of a New Polymeric Nanocarrier Dedicated to Controlled Clozapine Delivery at the Dopamine D2-Serotonin 5-HT1A Heteromers. | Polymers (Basel) | 2021 | https://conductscience.org/library/papers/33805130 | PubMed |
| 33602344 | Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems. | J Cannabis Res | 2021 | https://conductscience.org/library/papers/33602344 | PubMed |
| 33414418 | Towards in vivo imaging of functionally active 5-HT1A receptors in schizophrenia: concepts and challenges. | Transl Psychiatry | 2021 | https://conductscience.org/library/papers/33414418 | PubMed |
| 32726254 | Current Understanding of the Neurobiology of Agitation. | West J Emerg Med | 2020 | https://conductscience.org/library/papers/32726254 | PubMed |
| 32215360 | Restless legs syndrome following the use of ziprasidone: a case report. | Gen Psychiatr | 2020 | https://conductscience.org/library/papers/32215360 | PubMed |
| 32209227 | Identification of slit3 as a locus affecting nicotine preference in zebrafish and human smoking behaviour. | Elife | 2020 | https://conductscience.org/library/papers/32209227 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HTR1A | 3350 | PubTator's text mining | https://conductscience.org/library/genes/3350 | NCBI Gene |
| HTR2A | 3356 | PubTator's text mining | https://conductscience.org/library/genes/3356 | NCBI Gene |
| PRL | 5617 | PubTator's text mining | https://conductscience.org/library/genes/5617 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21394633
GET https://conductscience.org/api/papers/v1/21394633/references?page=2